These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25052042)

  • 1. Tissues cIMPly do not lie.
    Gao Y; Vanhoutte PM
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Sep; 387(9):901-3. PubMed ID: 25052042
    [No Abstract]   [Full Text] [Related]  

  • 2. Is cIMP a second messenger with functions opposite to those of cGMP?
    Seifert R
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Sep; 387(9):897-9. PubMed ID: 25017018
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypoxic Vasospasm Mediated by cIMP: When Soluble Guanylyl Cyclase Turns Bad.
    Gao Y; Chen Z; Leung SW; Vanhoutte PM
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):545-8. PubMed ID: 25264755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: development of a hypothesis based on studies with soluble guanylyl cyclase α(1)β(1).
    Beste KY; Seifert R
    Biol Chem; 2013 Feb; 394(2):261-70. PubMed ID: 23087103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cIMP synthesized by sGC as a mediator of hypoxic contraction of coronary arteries.
    Chen Z; Zhang X; Ying L; Dou D; Li Y; Bai Y; Liu J; Liu L; Feng H; Yu X; Leung SW; Vanhoutte PM; Gao Y
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H328-36. PubMed ID: 24906916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3',5'-cIMP as Potential Second Messenger in the Vascular Wall.
    Leung SWS; Gao Y; Vanhoutte PM
    Handb Exp Pharmacol; 2017; 238():209-228. PubMed ID: 26721675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries.
    Chan CK; Mak J; Gao Y; Man RY; Vanhoutte PM
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2313-21. PubMed ID: 21984543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of soluble guanylate cyclase in hypoxic and hypercapnic rat lung].
    Xia Xd; Xu ZJ; Bi YT
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2003 May; 19(2):159-60. PubMed ID: 21207666
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1.
    Beste KY; Burhenne H; Kaever V; Stasch JP; Seifert R
    Biochemistry; 2012 Jan; 51(1):194-204. PubMed ID: 22122229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells.
    Bähre H; Danker KY; Stasch JP; Kaever V; Seifert R
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1195-9. PubMed ID: 24380860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
    Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
    Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles for redox mechanisms controlling protein kinase G in pulmonary and coronary artery responses to hypoxia.
    Neo BH; Kandhi S; Wolin MS
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2295-304. PubMed ID: 21926339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic augmentation: The tale of a strange contraction.
    Vanhoutte PM; Leung SWS
    Basic Clin Pharmacol Toxicol; 2020 Aug; 127(2):59-66. PubMed ID: 31310708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of cGMP and soluble guanylyl cyclase activity.
    Southam E
    Curr Protoc Toxicol; 2001 May; Chapter 10():Unit 10.5. PubMed ID: 23045027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-fat diet-induced obesity leads to increased NO sensitivity of rat coronary arterioles: role of soluble guanylate cyclase activation.
    Jebelovszki E; Kiraly C; Erdei N; Feher A; Pasztor ET; Rutkai I; Forster T; Edes I; Koller A; Bagi Z
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2558-64. PubMed ID: 18408126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of cGMP signalling protects coronary endothelium against reperfusion-induced intercellular gap formation.
    Kasseckert SA; Schäfer C; Kluger A; Gligorievski D; Tillmann J; Schlüter KD; Noll T; Sauer H; Piper HM; Abdallah Y
    Cardiovasc Res; 2009 Jul; 83(2):381-7. PubMed ID: 19234300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological stimulation of soluble guanylate cyclase modulates hypoxia-inducible factor-1alpha in rat heart.
    Tsuruda T; Hatakeyama K; Masuyama H; Sekita Y; Imamura T; Asada Y; Kitamura K
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1274-80. PubMed ID: 19684186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
    Bice JS; Keim Y; Stasch JP; Baxter GF
    Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidic triazoles as soluble guanylate cyclase stimulators.
    Roberts LR; Bradley PA; Bunnage ME; England KS; Fairman D; Fobian YM; Fox DN; Gymer GE; Heasley SE; Molette J; Smith GL; Schmidt MA; Tones MA; Dack KN
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6515-8. PubMed ID: 21924901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conventional and Unconventional Mechanisms for Soluble Guanylyl Cyclase Signaling.
    Gao Y
    J Cardiovasc Pharmacol; 2016 May; 67(5):367-72. PubMed ID: 26452163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.